about
Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseasesHuman iPSC for Therapeutic Approaches to the Nervous System: Present and Future ApplicationsInduced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discoveryGenetic disorders coupled to ROS deficiencyTapping Stem Cells to Target AMD: Challenges and ProspectsClinical implications of basic science discoveries: induced pluripotent stem cell therapy in transplantation--a potential role for immunologic toleranceThe Oct4 protein: more than a magic stemness markerDeciphering Human Cell-Autonomous Anti-HSV-1 Immunity in the Central Nervous SystemA brief review of recent Charcot-Marie-Tooth research and prioritiesGlycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG)Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug DiscoveryTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicinePotential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)Rethinking differentiation: stem cells, regeneration, and plasticityDifferentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays.Enhanced derivation of human pluripotent stem cell-derived cortical glutamatergic neurons by a small molecule.Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells.Convergence of stem cell behaviors and genetic regulation between animals and plants: insights from the Arabidopsis thaliana stomatal lineage.A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy.Finding degrees of separation: experimental approaches for astroglial and oligodendroglial cell isolation and genetic targetingRecessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.Promoting effect of 1,25(OH)2 vitamin D3 in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells.Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kindLaser-assisted generation of human induced pluripotent stem cells.Human induced hepatic lineage-oriented stem cells: autonomous specification of human iPS cells toward hepatocyte-like cells without any exogenous differentiation factors.Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming.Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosaProductive Infection of Human Embryonic Stem Cell-Derived NKX2.1+ Respiratory Progenitors with Human Rhinovirus.Development of Lung Epithelium from Induced Pluripotent Stem Cells.Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed CellsMurine Embryonic Stem Cell Plasticity Is Regulated through Klf5 and Maintained by Metalloproteinase MMP1 and Hypoxia.Scalable topographies to support proliferation and Oct4 expression by human induced pluripotent stem cells.Genome-wide association studies and contribution to cardiovascular physiologyToward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT SyndromeOscillating high-aspect-ratio monolithic silicon nanoneedle array enables efficient delivery of functional bio-macromolecules into living cells.Matrix-assisted laser desorption/ionization imaging mass spectrometry reveals changes of phospholipid distribution in induced pluripotent stem cell colony differentiation.Nuclear transcriptome profiling of induced pluripotent stem cells and embryonic stem cells identify non-coding loci resistant to reprogrammingRapid and robust generation of long-term self-renewing human neural stem cells with the ability to generate mature astroglia.Enhancing mammary differentiation by overcoming lineage-specific epigenetic modification and signature gene expression of fibroblast-derived iPSCs.The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.
P2860
Q26750384-074F43B6-AA0B-4E3F-B7CF-B2A71AD07050Q26772309-EBA3F626-FE13-476C-BEF5-7DF5CF8CC356Q26781825-44973FEA-DE6B-4FA9-B7ED-38B750F31FD8Q26799545-3DB0C900-F97D-4D5C-8CB4-9C374C9B80BEQ26799625-B28776E3-E4F9-41DA-A033-7770F74F022CQ26824632-BA44D9E8-E682-44A7-83EE-B49D4E76D19EQ26862078-B7F79F06-63A4-4FF5-9352-5AC6D8E8D7EDQ26991623-7EB36BF6-DFF3-403E-9893-3FC44E1EBA47Q27012700-2236865D-42ED-4436-A65C-1E7382BAFEDEQ27311626-D4357823-3C87-482B-BCCD-838428232271Q28072402-18F25D1F-12C3-46EE-B7BB-5294FD89C6BFQ28076397-3AD3B73B-D858-4B7B-8208-09D156FCDFA9Q28077285-8918338C-76BB-462C-B301-4208829500B5Q28656516-5A6DCCA0-840A-4A03-92EB-5E434CB037ABQ33659124-A305731C-7E78-4C9F-AFE6-0D75D068C790Q33789516-C0D1B3BD-450E-4B4E-BD6B-6A720A5D5329Q33911278-BBD4C7AC-3184-4E3D-8B4D-23832F7991ACQ33942088-64652F2D-764A-4A30-B603-2481EE15FB92Q34044757-12F558A8-3957-4F11-9CD3-A689DB79EACBQ34224054-EC519E7D-4265-4EF2-981E-ED7FF3150F52Q34752070-700B28B9-15F5-4900-B884-291CFF7C8A45Q35133864-11A445C5-7C2D-4EBF-BC90-33A1FD53F4C1Q35190461-311C0510-9856-45F8-A33F-08E7CA0129C8Q35389798-383D6EDD-3566-4679-8030-1826E2201A6CQ35393151-35AC3B2B-8CAF-4B69-878F-F96CF1F1E40AQ35486433-12EA49AB-2183-4E10-920F-97E695FFA566Q35597980-3DC9401F-DD00-4297-AEAB-B74DF7AC6150Q35665334-E642C574-3509-4832-AAC4-FA49627C6B04Q35674313-9BBDBF5E-29E2-43C5-8557-B178A3ED2243Q35747887-B7E04E70-8E57-4FE4-8852-BBC65BEC278BQ35885664-C41BD107-E5E7-453C-AC7D-21E8FF2AC84CQ35891769-5E46840E-575F-44D7-A551-0A4382B23411Q36017794-22B76CA7-CC4E-4CAC-B036-26F6A7774FBEQ36141836-D8C887FF-D2D3-4561-B3C4-BA838B750F4DQ36168124-3139109B-9097-4DF2-AEEA-B6D7E1F917E1Q36183378-B50EEA9C-55B8-4FCC-A6A5-C3BDA1E187A1Q36184853-39EC95A3-2A7A-476B-ABBF-01B279D9299FQ36254742-4D734027-2F02-40B6-84B3-040874AD7BB8Q36291965-7A889DFB-9EF0-44D5-8E68-E4A466743950Q36695546-1B3DC3D8-4028-412A-9597-3FFDF8C57D85
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
iPS cells: a game changer for future medicine.
@en
type
label
iPS cells: a game changer for future medicine.
@en
prefLabel
iPS cells: a game changer for future medicine.
@en
P2093
P2860
P356
P1433
P1476
iPS cells: a game changer for future medicine.
@en
P2093
Haruhisa Inoue
Hiromi Kurokawa
Naoki Nagata
P2860
P304
P356
10.1002/EMBJ.201387098
P407
P577
2014-02-05T00:00:00Z